National Health Investors, Inc. (NYSE:NHI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Friday. The firm presently has a $89.00 price objective on the real estate investment trust’s stock. Zacks Investment Research‘s price target would suggest a potential upside of 11.35% from the company’s current price.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
Other analysts have also recently issued reports about the stock. BidaskClub cut shares of National Health Investors from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Mizuho restated a “neutral” rating on shares of National Health Investors in a report on Wednesday, June 28th. Stifel Nicolaus raised their price target on shares of National Health Investors from $80.00 to $82.00 and gave the stock a “buy” rating in a report on Wednesday, June 21st. ValuEngine cut shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, June 13th. Finally, Bank of America Corporation cut shares of National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 price target for the company. in a report on Monday, May 22nd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $80.50.
National Health Investors (NYSE:NHI) opened at 79.93 on Friday. National Health Investors has a 12 month low of $66.31 and a 12 month high of $81.29. The company’s 50-day moving average is $78.47 and its 200 day moving average is $75.92. The firm has a market cap of $3.28 billion, a price-to-earnings ratio of 20.53 and a beta of 0.56.
National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing the consensus estimate of $1.29 by ($0.36). The company had revenue of $69.84 million for the quarter, compared to analyst estimates of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The business’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.22 earnings per share. On average, equities research analysts predict that National Health Investors will post $3.85 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: This piece of content was reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.chaffeybreeze.com/2017/09/15/national-health-investors-inc-nhi-upgraded-at-zacks-investment-research.html.
In other National Health Investors news, insider Kevin Carlton Pascoe sold 2,000 shares of National Health Investors stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the completion of the sale, the insider now directly owns 21,228 shares in the company, valued at $1,693,994.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 5.19% of the stock is owned by insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Schwab Charles Investment Management Inc. lifted its stake in National Health Investors by 9.7% in the first quarter. Schwab Charles Investment Management Inc. now owns 161,309 shares of the real estate investment trust’s stock valued at $11,716,000 after acquiring an additional 14,297 shares during the last quarter. BlackRock Inc. lifted its stake in National Health Investors by 6,473.4% in the first quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock valued at $241,753,000 after acquiring an additional 3,277,930 shares during the last quarter. Bank of America Corp DE lifted its stake in National Health Investors by 2.5% in the first quarter. Bank of America Corp DE now owns 388,780 shares of the real estate investment trust’s stock valued at $28,238,000 after acquiring an additional 9,538 shares during the last quarter. Daiwa Securities Group Inc. lifted its stake in National Health Investors by 1.7% in the first quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock valued at $232,000 after acquiring an additional 55 shares during the last quarter. Finally, UBS Group AG lifted its stake in National Health Investors by 57.9% in the first quarter. UBS Group AG now owns 43,401 shares of the real estate investment trust’s stock valued at $3,152,000 after acquiring an additional 15,918 shares during the last quarter. Hedge funds and other institutional investors own 70.58% of the company’s stock.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.